Anti-glomerular Basement Membrane Antibody Disease

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2022-04-07
Clinical Trial Update: Open-Label Phase II Study to Evaluate the Efficacy and Safety of IdeS in Anti-GBM Disease [Phase 2]
Phase II open-label study evaluating IdeS for anti-GBM disease has completed; results posted in 2022.